The value of angiotensin Ii
Allain, P.
Presse Medicale 29(35): 1947
2000
ISSN/ISBN: 0755-4982 PMID: 11244628 Document Number: 518154
Document emailed within 1 workday
Related Documents
Ripka, O.; Ort, J.; Linhartová, J.; Tvrzická, E.; Reinisová, J. 1972: Renin-angiotensin system in the diagnosis of renovascular hypertension. Radioimmunoassay of angiotensin i and angiotensin Ii Casopis Lekaru Ceskych 111(35): 818-820Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Lijnen, P.J.; Fagard, R.H.; Amery, A.K. 1979: Effects of angiotensin Ii and 1-Sar-8-Ala-angiotensin Ii on the renal function in sodium-replete and -deplete dogs Archives Internationales de Physiologie et de Biochimie 87(1): 193-194
Ercan, Z.S.; Ersoy, F.F.; Türker, R.K.; Bor, N. 1978: The relaxing effects of angiotensin II and angiotensin III on canine isolated contracted tracheal muscle Journal of Pharmacy and Pharmacology 30(7): 452-453
Ménard, J. 1993: Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 11(3): S3-11
Pendleton, R.G.; Gessner, G.; Horner, E. 1991: Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues Journal of Pharmacology and Experimental Therapeutics 256(2): 614-620
Küppers, H.; Wiesen, K.; Schnurr, E.; Grabensee, B. 1976: Determination of angiotensin Ii in plasma. Studies on the renin-angiotensin-aldosterone system Die Medizinische Welt 27(47): 2286-2288
Novo, S.; Adamo, L.; Giamporcaro, A.; Forte, G.; Longo, B.; Gallo, V.B.; Licata, G.; Strano, A. 1987: Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs) Agents and Actions. Supplements 22: 339-347
Aurell, M. 1984: Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
Falch, D. 1983: Saralasin in the diagnosis of angiotensin-dependent hypertension and in the study of the renin-angiotensin-aldosterone system Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(11): 906-908
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Haznedaroğlu, I.C. 1997: Angiotensin I-converting enzyme, blood groups, and a local marrow-specific renin-angiotensin system Experimental Hematology 25(2): 93
Qadri, F.; Culman, J.; Veltmar, A.; Maas, K.; Rascher, W.; Unger, T. 1993: Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin Ii AT1 receptors in the supraoptic nucleus Journal of Pharmacology and Experimental Therapeutics 267(2): 567-574
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57
Zou, L.X.; Hymel, A.; Imig, J.D.; Navar, L.G. 1996: Renal accumulation of circulating angiotensin II in angiotensin II-infused rats Hypertension 27(3 Pt 2): 658-662
Vallotton, M.B. 1971: Parallel radioimmunoassays of angiotensin i and of angiotensin Ii for measurement of renin activity and of circulating active hormone in human plasma Hormone and Metabolic Research 3(Suppl 3): 94-100
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47